Advancements in Cervical Cancer & the Role of Biomarkers

Host: Charles Turck, PharmD, BCPS, BCCCP <br> Guest: Lee P. Shulman, MD, FACMG, FACOG <br> <p>Cervical cancer is the fourth most common cancer in women worldwide, which makes it essential for us to keep ahead of advances in cervical cancer prevention—advances like a biomarker-based cytology test. Here to discuss this and other recent advancements in cervical cancer screening is Dr. Lee Shulman, the Anna Ross Lapham Professor in Obstetrics and Gynecology in the Division of Clinical Genetics at the Feinberg School of Medicine at Northwestern University.</p>